Medication use and disease management of type 2 diabetic flemish patients
- 293 Downloads
Objective The aim of this study was (International Diabetes Federation. Diabetes Atlas Second Edition Executive Summary. Brussels: International Diabetes Federation; 2003) to describe the current status of medication use and disease management of type 2 diabetic patients in Flanders (Belgium), (World Health Organization. Prevention of diabetes mellitus. Technical report series no. 844. Geneva: World Health Organization; 1994) to identify the aspects of type 2 diabetes care a community pharmacist could provide additional educational services for, and (American Diabetes Association. Diabetes Care 2006;29:S4–42) to propose these services as a pharmacist intervention. Method We recruited 338 patients in 77 community pharmacies in Flanders (Belgium). Each patient completed a questionnaire collecting personal data, information on duration of diabetes, medication, diabetes symptoms and self-management. At inclusion, patients measured their fasting plasma glucose (FPG) on three consecutive days. Prescription drugs (antidiabetic and other) purchased by each patient during the 12 months prior to inclusion in the study were reviewed from anonymized computerized pharmacy records. Main outcome measures Degree of self-management, glycaemic control and medication use. Results The mean FPG of the sample was 150.7 ± 43.0 mg/dl. Controlled glycaemia (FPG between 90 and 130 mg/dl (5.0–7.2 mmol/l)) was achieved in only 34.9% of the patients. Mainstay of hypoglycemic treatment consisted of metformin monotherapy (29.6%) and metformin combined with sulfonylurea (29.0%). Regarding co-medication, 76.9% of the patients used antihypertensive drugs whereas only 33.1% and 39.9% were on aspirin and statin therapy, respectively. ADA recommendations for annual eye and foot examination were not followed in 38.8% (eye) and 39.2% (feet) of the patients. Conclusion The current management of type 2 diabetic Flemish patients falls short of recommended treatment goals. Community pharmacists may play a role in enhancing the awareness of glycaemic control and in stimulating selfmanagement in diabetic patients by motivating patients towards correct medication use, better medication adherence, healthy lifestyle and smoking cessation.
KeywordsType 2 diabetes Pharmacotherapy Self-management Community pharmacists Belgium
We wish to thank the students and supervising pharmacists for their efforts in conducting this survey, and all patients who kindly agreed to participate in the study and gave their permission to publish the results. Financially supported by Ghent University.
- 1.International Diabetes Federation. Diabetes Atlas Second Edition Executive Summary. Brussels: International Diabetes Federation; 2003. ISBN 2 930229 28 4. www.eatlas.idf.org (accessed 2006 Oct 10).Google Scholar
- 2.World Health Organization. Prevention of diabetes mellitus. Technical report series no. 844. Geneva: World Health Organization; 1994. ISBN 92 4 120844 9.Google Scholar
- 3.American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2006;29:S4–42.Google Scholar
- 10.Clifford RM, Batty KT, Davis TM, et al. A randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic. Int J Pharm Pract 2002;10:85–9.Google Scholar
- 17.Welschen LM, Bloemendal E, Nijpels G, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin. Cochrane Database Syst Rev 2005;18:CD005060.Google Scholar
- 26.Bayingana K, Demarest S, Gisle L, et al. Gezondheidsenquête België 2004. Wetenschappelijk Instituut Volksgezondheid, Brussels, Belgium, 2006 (IPH/EPI Reports nr 2006–035). www.iph.fgov.be/epidemio/epinl/crospnl/hisnl/his04nl/his35nl.pdf (accessed 2006 Oct 10).Google Scholar